首页 › 基金 › GLENVIEW CAPITAL MANAGEMENT, LLC › TEVA

GLENVIEW CAPITAL MANAGEMENT, LLC 对 TEVA 的持仓历史

TEVA PHARMACEUTICAL INDS LTD · 医疗保健

GLENVIEW CAPITAL MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 TEVA(TEVA PHARMACEUTICAL INDS LTD)7,566,877 股,市值约 US$299.6M,约占其申报组合的 5.39%,在其申报持仓中市值排名第 5 位。 GLENVIEW CAPITAL MANAGEMENT, LLC 最近 12 个申报季度中有 12 个季度披露了 TEVA 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)7.57M 股
申报持仓市值$299.65M
组合权重5.39%
首次申报Q4 2023
最近变动增持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

GLENVIEW CAPITAL MANAGEMENT, LLC 对 TEVA 的持仓演变

GLENVIEW CAPITAL MANAGEMENT, LLC 于 Q4 2023 首次披露 TEVA 持仓:1,604,633 股(约 US$16.8M)。 该持仓在 Q4 2025 达到峰值 16,720,209 股,市值约 US$521.8M。 在 12 次申报中,GLENVIEW CAPITAL MANAGEMENT, LLC 6 次增持、3 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 7,566,877 股、市值约 US$299.6M,环比增持 2,485,786 股。。 持仓曾出现大幅变动:Q1 2024 增持约 367% (随后一个季度股价上涨 15%)、Q1 2025 增持约 75% (随后一个季度股价上涨 9%)、Q1 2026 减持约 60% (随后一个季度股价上涨 12%)。

逐季持仓明细

季度股数金额变化
Q4 2023 1.60M $16.75M 新进
Q1 2024 7.50M $105.84M 增持
Q2 2024 9.16M $148.81M 增持
Q3 2024 8.46M $152.38M 减持
Q4 2024 8.46M $186.38M 持有
Q1 2025 14.78M $227.15M 增持
Q2 2025 15.82M $265.21M 增持
Q3 2025 16.69M $337.19M 增持
Q4 2025 16.72M $521.84M 持有
Q1 2026 6.66M $200.61M 减持
Q2 2026 5.08M $172.15M 减持
Q3 2026 7.57M $299.65M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 TEVA 与 13F 数据

TEVA(TEVA PHARMACEUTICAL INDS LTD)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 TEVA,申报仓位最大的包括:BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TEVA 的基金

查看 TEVA 的全部基金持有人 →

常见问题

How long has GLENVIEW CAPITAL MANAGEMENT, LLC held TEVA?

GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in TEVA?

As of Q3 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 7.57M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $299.65M, representing 5.39% of its reported portfolio and ranking #5.

Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling TEVA?

In the latest 13F filing (Q3 2026), GLENVIEW CAPITAL MANAGEMENT, LLC increased its position in TEVA. The position peaked in Q4 2025 at 16.72M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.